APPUI MEDICAL INVESTISSEMENTS : revenue, balance sheet and financial ratios

APPUI MEDICAL INVESTISSEMENTS is a French company founded 6 years ago, specialized in the sector Gestion de fonds. Based in YVRAC (33370), this company of category PME shows in 2023 a revenue of 6 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - APPUI MEDICAL INVESTISSEMENTS (SIREN 851454223)
Indicator 2025 2024 2023 2022
Revenue N/C N/C 6 126 € 339 088 €
Net income 12 050 € -15 024 € -1 131 € 72 982 €
EBITDA -3 050 € -10 058 € -14 029 € 45 893 €
Net margin N/C N/C -18.5% 21.5%

Revenue and income statement

In 2025, APPUI MEDICAL INVESTISSEMENTS generates positive net income of 12 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2022-2025: 73 k€ -> 12 k€.

EBITDA (2025) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-3 050 €

EBIT (2025) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-4 836 €

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

12 050 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 20%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 8%. Low autonomy: the company heavily depends on external financing (banks, suppliers). Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 2.2 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

19.973%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

8.363%

Repayment capacity (2025) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

2.242

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

68.9%

Solvency indicators evolution
APPUI MEDICAL INVESTISSEMENTS

Sector positioning

Debt ratio
19.97 2025
2023
2024
2025
Q1: 0.0
Med: 11.05
Q3: 95.39
Average -8 pts over 3 years

In 2025, the debt ratio of APPUI MEDICAL INVESTISSEM... (19.97) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
8.36% 2025
2023
2024
2025
Q1: 9.39%
Med: 52.08%
Q3: 89.29%
Average -7 pts over 3 years

In 2025, the financial autonomy of APPUI MEDICAL INVESTISSEM... (8.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
2.24 years 2025
2023
2024
2025
Q1: 0.0 years
Med: 0.12 years
Q3: 3.48 years
Average -9 pts over 3 years

In 2025, the repayment capacity of APPUI MEDICAL INVESTISSEM... (2.24) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 102.17. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

102.172

Interest coverage (2025) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-237.016

Liquidity indicators evolution
APPUI MEDICAL INVESTISSEMENTS

Sector positioning

Liquidity ratio
102.17 2025
2023
2024
2025
Q1: 117.65
Med: 590.18
Q3: 4189.62
Watch

In 2025, the liquidity ratio of APPUI MEDICAL INVESTISSEM... (102.17) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Interest coverage
-237.02x 2025
2023
2024
2025
Q1: -77.28x
Med: 0.0x
Q3: 0.0x
Average -9 pts over 3 years

In 2025, the interest coverage of APPUI MEDICAL INVESTISSEM... (-237.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 62 days. Excellent situation: suppliers finance 62 days of the operating cycle (retail model).

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

62 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
APPUI MEDICAL INVESTISSEMENTS

Positioning of APPUI MEDICAL INVESTISSEMENTS in its sector

Comparison with sector Gestion de fonds

Valuation estimate

Indicative estimate only : the number of comparable transactions in this sector is limited (40 transactions). This range of 15 645€ to 90 162€ is provided for information purposes only and requires in-depth analysis to be confirmed.

Estimated enterprise value 2025
Indicative
15k€ 30k€ 90k€
30 859 € Range: 15 645€ - 90 162€
NAF 5 année 2025

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 40 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Gestion de fonds)

Compare APPUI MEDICAL INVESTISSEMENTS with other companies in the same sector:

Frequently asked questions about APPUI MEDICAL INVESTISSEMENTS

What is the revenue of APPUI MEDICAL INVESTISSEMENTS ?

The revenue of APPUI MEDICAL INVESTISSEMENTS in 2023 is 6 k€.

Is APPUI MEDICAL INVESTISSEMENTS profitable?

Yes, APPUI MEDICAL INVESTISSEMENTS generated a net profit of 12 k€ in 2025.

Where is the headquarters of APPUI MEDICAL INVESTISSEMENTS ?

The headquarters of APPUI MEDICAL INVESTISSEMENTS is located in YVRAC (33370), in the department Gironde.

Where to find the tax return of APPUI MEDICAL INVESTISSEMENTS ?

The tax return of APPUI MEDICAL INVESTISSEMENTS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does APPUI MEDICAL INVESTISSEMENTS operate?

APPUI MEDICAL INVESTISSEMENTS operates in the sector Gestion de fonds (NAF code 66.30Z). See the 'Sector positioning' section above to compare the company with its competitors.